[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 3036 Reported in Senate (RS)]
Calendar No. 675
111th CONGRESS
2d Session
S. 3036
To establish the Office of the National Alzheimer's Project.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
February 24, 2010
Mr. Bayh (for himself, Ms. Collins, Mr. LeMieux, Mr. Tester, Mr.
Whitehouse, Ms. Landrieu, Mr. Feingold, Ms. Stabenow, Mr. Conrad, Mrs.
McCaskill, Mr. Chambliss, Mr. Schumer, Mrs. Gillibrand, Mr. Lieberman,
Mr. Johnson, Mr. Menendez, Mr. Gregg, Mr. Lautenberg, Mr. Warner, Mr.
Carper, Mr. Bennet, Mr. Casey, Ms. Cantwell, Mr. Akaka, Mr. Cardin, Mr.
Kohl, Mrs. Shaheen, Mr. Dodd, Mrs. Lincoln, Mrs. Boxer, Ms. Snowe, Mr.
Kaufman, Mr. Inouye, and Mr. Burr) introduced the following bill; which
was read twice and referred to the Committee on Health, Education,
Labor, and Pensions
December 6, 2010
Reported by Mr. Harkin, with an amendment and an amendment to the title
[Strike out all after the enacting clause and insert the part printed
in italic]
_______________________________________________________________________
A BILL
To establish the Office of the National Alzheimer's Project.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
<DELETED>SECTION 1. SHORT TITLE.</DELETED>
<DELETED> This Act may be cited as the ``National Alzheimer's
Project Act''.</DELETED>
<DELETED>SEC. 2. OFFICE OF THE NATIONAL ALZHEIMER'S PROJECT.</DELETED>
<DELETED> (a) Establishment of Office.--There is established in the
Office of the Secretary of Health and Human Services the Office of the
National Alzheimer's Project (referred to in this Act as the
``Office'').</DELETED>
<DELETED> (b) Purpose of the Office.--The Office shall--</DELETED>
<DELETED> (1) accelerate the development of treatments that
would prevent, halt, or reverse the course of
Alzheimer's;</DELETED>
<DELETED> (2) be responsible for the creation and
maintenance of an integrated national plan to overcome
Alzheimer's;</DELETED>
<DELETED> (3) help to coordinate the health care and
treatment of citizens with Alzheimer's;</DELETED>
<DELETED> (4) ensure the inclusion of ethnic and racial
populations at higher risk for Alzheimer's or least likely to
receive care, in clinical, research, and service efforts with
the purpose of decreasing health disparities in
Alzheimer's;</DELETED>
<DELETED> (5) coordinate with international bodies to
integrate and inform the fight against Alzheimer's globally;
and</DELETED>
<DELETED> (6) provide information and coordination of
Alzheimer's research and services across all Federal
agencies.</DELETED>
<DELETED> (c) Director of the Office.--</DELETED>
<DELETED> (1) Appointment.--The President shall appoint a
Director of the Office.</DELETED>
<DELETED> (2) Duties of the director.--</DELETED>
<DELETED> (A) In general.--The Director of the
Office shall--</DELETED>
<DELETED> (i) oversee the creation and
updating of the national plan described in
subparagraph (B);</DELETED>
<DELETED> (ii) use discretionary authority
to evaluate all Federal programs around
Alzheimer's, including budget requests and
approvals; and</DELETED>
<DELETED> (iii) prepare and submit to the
President the annual budget estimate for the
Office.</DELETED>
<DELETED> (B) National plan.--The Director of the
Office shall carry out an annual assessment of the
Nation's progress in preparing for the escalating
burden of Alzheimer's, including both implementation
steps and recommendations for priority actions based on
the assessment.</DELETED>
<DELETED> (3) Service by director.--The Director of the
Office shall serve on the advisory board of the Office of
Science and Technology to promote research efforts into
mechanisms to slow and stop the development of Alzheimer's for
those at risk of developing the disease.</DELETED>
<DELETED> (d) Advisory Council.--</DELETED>
<DELETED> (1) In general.--There is established in the
Office an Advisory Council on Alzheimer's Research and
Treatment (referred to in this Act as the ``Advisory
Council'').</DELETED>
<DELETED> (2) Membership.--</DELETED>
<DELETED> (A) Federal members.--The Advisory Council
shall be comprised of the following experts:</DELETED>
<DELETED> (i) A designee of the Centers for
Disease Control and Prevention.</DELETED>
<DELETED> (ii) A designee of the
Administration on Aging.</DELETED>
<DELETED> (iii) A designee of the Centers
for Medicare & Medicaid Services.</DELETED>
<DELETED> (iv) A designee of the Indian
Health Service.</DELETED>
<DELETED> (v) A designee of the Office of
the Director of the National Institutes of
Health.</DELETED>
<DELETED> (vi) The Surgeon
General.</DELETED>
<DELETED> (vii) A designee of the National
Science Foundation.</DELETED>
<DELETED> (viii) A designee of the
Department of Veterans Affairs.</DELETED>
<DELETED> (B) Non-federal members.--In addition to
the members outlined in subparagraph (A), the Advisory
Council shall include 12 expert members from outside
the Federal Government, which shall include--</DELETED>
<DELETED> (i) 2 Alzheimer patient
advocates;</DELETED>
<DELETED> (ii) 2 Alzheimer
caregivers;</DELETED>
<DELETED> (iii) 2 health care
providers;</DELETED>
<DELETED> (iv) 2 representatives of State
health departments;</DELETED>
<DELETED> (v) 2 researchers with Alzheimer-
related expertise in basic, translational,
clinical, or drug development science;
and</DELETED>
<DELETED> (vi) 2 voluntary health
association representatives, including a
national Alzheimer's disease organization that
funds research and has demonstrated experience
in care and patient services, and a State-based
advocacy organization that provides services to
families and professionals, including
information and referral, support groups, care
consultation, education, and safety
services.</DELETED>
<DELETED> (3) Meetings.--The Advisory Council shall meet
quarterly and such meetings shall be open to the
public.</DELETED>
<DELETED> (4) Advice.--The Advisory Council shall advise the
Director of the Office.</DELETED>
<DELETED> (5) Annual report.--The Advisory Council shall
provide to the Director of the Office--</DELETED>
<DELETED> (A) recommendations for information to be
included in the annual report to Congress by the
Office; and</DELETED>
<DELETED> (B) an annually updated national
plan.</DELETED>
<DELETED> (e) Annual Report.--The Director of the Office shall
submit to Congress--</DELETED>
<DELETED> (1) an annual report that includes an evaluation
of all nationally and federally funded efforts in Alzheimer's
research, clinical care, institutional, and home- and
community-based programs and their outcomes; and</DELETED>
<DELETED> (2) an annually updated national plan.</DELETED>
<DELETED> (f) Sunset.--The Office shall expire on December 31,
2025.</DELETED>
SECTION 1. SHORT TITLE.
This Act may be cited as the ``National Alzheimer's Project Act''.
SEC. 2. THE NATIONAL ALZHEIMER'S PROJECT.
(a) Definition of Alzheimer's.--In this Act, the term
``Alzheimer's'' means Alzheimer's disease and related dementias.
(b) Establishment.--There is established in the Office of the
Secretary of Health and Human Services the National Alzheimer's Project
(referred to in this Act as the ``Project'').
(c) Purpose of the Project.--The Secretary of Health and Human
Services, or the Secretary's designee, shall--
(1) be responsible for the creation and maintenance of an
integrated national plan to overcome Alzheimer's;
(2) provide information and coordination of Alzheimer's
research and services across all Federal agencies;
(3) accelerate the development of treatments that would
prevent, halt, or reverse the course of Alzheimer's;
(4) improve the--
(A) early diagnosis of Alzheimer's disease; and
(B) coordination of the care and treatment of
citizens with Alzheimer's;
(5) ensure the inclusion of ethnic and racial populations
at higher risk for Alzheimer's or least likely to receive care,
in clinical, research, and service efforts with the purpose of
decreasing health disparities in Alzheimer's; and
(6) coordinate with international bodies to integrate and
inform the fight against Alzheimer's globally.
(d) Duties of the Secretary.--
(1) In general.--The Secretary of Health and Human
Services, or the Secretary's designee, shall--
(A) oversee the creation and updating of the
national plan described in paragraph (2); and
(B) use discretionary authority to evaluate all
Federal programs around Alzheimer's, including budget
requests and approvals.
(2) National plan.--The Secretary of Health and Human
Services, or the Secretary's designee, shall carry out an
annual assessment of the Nation's progress in preparing for the
escalating burden of Alzheimer's, including both implementation
steps and recommendations for priority actions based on the
assessment.
(e) Advisory Council.--
(1) In general.--There is established an Advisory Council
on Alzheimer's Research, Care, and Services (referred to in
this Act as the ``Advisory Council'').
(2) Membership.--
(A) Federal members.--The Advisory Council shall be
comprised of the following experts:
(i) A designee of the Centers for Disease
Control and Prevention.
(ii) A designee of the Administration on
Aging.
(iii) A designee of the Centers for
Medicare & Medicaid Services.
(iv) A designee of the Indian Health
Service.
(v) A designee of the Office of the
Director of the National Institutes of Health.
(vi) The Surgeon General.
(vii) A designee of the National Science
Foundation.
(viii) A designee of the Department of
Veterans Affairs.
(ix) A designee of the Food and Drug
Administration.
(x) A designee of the Agency for Healthcare
Research and Quality.
(B) Non-federal members.--In addition to the
members outlined in subparagraph (A), the Advisory
Council shall include 12 expert members from outside
the Federal Government, which shall include--
(i) 2 Alzheimer's patient advocates;
(ii) 2 Alzheimer's caregivers;
(iii) 2 health care providers;
(iv) 2 representatives of State health
departments;
(v) 2 researchers with Alzheimer's-related
expertise in basic, translational, clinical, or
drug development science; and
(vi) 2 voluntary health association
representatives, including a national
Alzheimer's disease organization that has
demonstrated experience in research, care, and
patient services, and a State-based advocacy
organization that provides services to families
and professionals, including information and
referral, support groups, care consultation,
education, and safety services.
(3) Meetings.--The Advisory Council shall meet quarterly
and such meetings shall be open to the public.
(4) Advice.--The Advisory Council shall advise the
Secretary of Health and Human Services, or the Secretary's
designee.
(5) Annual report.--The Advisory Council shall provide to
the Secretary of Health and Human Services, or the Secretary's
designee and Congress--
(A) an initial evaluation of all federally funded
efforts in Alzheimer's research, clinical care, and
institutional-, home-, and community-based programs and
their outcomes;
(B) initial recommendations for priority actions to
expand, eliminate, coordinate, or condense programs
based on the program's performance, mission, and
purpose;
(C) initial recommendations to--
(i) reduce the financial impact of
Alzheimer's on--
(I) Medicare and other federally
funded programs; and
(II) families living with
Alzheimer's disease; and
(ii) improve health outcomes; and
(D) annually thereafter, an evaluation of the
implementation, including outcomes, of the
recommendations, including priorities if necessary,
through an updated national plan under subsection
(d)(2).
(6) Termination.--The Advisory Council shall terminate on
December 31, 2025.
(f) Data Sharing.--Agencies both within the Department of Health
and Human Services and outside of the Department that have data
relating to Alzheimer's shall share such data with the Secretary of
Health and Human Services, or the Secretary's designee, to enable the
Secretary, or the Secretary's designee, to complete the report
described in subsection (g).
(g) Annual Report.--The Secretary of Health and Human Services, or
the Secretary's designee, shall submit to Congress--
(1) an annual report that includes an evaluation of all
federally funded efforts in Alzheimer's research, clinical
care, and institutional-, home-, and community-based programs
and their outcomes;
(2) an evaluation of all federally funded programs based on
program performance, mission, and purpose related to
Alzheimer's disease;
(3) recommendations for--
(A) priority actions based on the evaluation
conducted by the Secretary and the Advisory Council
to--
(i) reduce the financial impact of
Alzheimer's on--
(I) Medicare and other federally
funded programs; and
(II) families living with
Alzheimer's disease; and
(ii) improve health outcomes;
(B) implementation steps; and
(C) priority actions to improve the prevention,
diagnosis, treatment, care, institutional-, home-, and
community-based programs of Alzheimer's disease for
individuals with Alzheimer's disease and their
caregivers; and
(4) an annually updated national plan.
(h) Sunset.--The Project shall expire on December 31, 2025.
Amend the title so as to read: ``A bill to establish the
National Alzheimer's Project.''.
Calendar No. 675
111th CONGRESS
2d Session
S. 3036
_______________________________________________________________________
A BILL
To establish the Office of the National Alzheimer's Project.
_______________________________________________________________________
December 6, 2010
Reported with an amendment and an amendment to the title